{
    "organizations": [],
    "uuid": "1b3741bab7e1d8cfd19816458f5aba8bdd25d325",
    "author": "",
    "url": "https://www.reuters.com/article/brief-abbvie-and-international-myeloma-f/brief-abbvie-and-international-myeloma-foundation-partner-to-study-role-of-genetic-mutation-idUSFWN1R30F4",
    "ord_in_thread": 0,
    "title": "BRIEF-AbbVie and International Myeloma Foundation Partner To Study Role Of Genetic Mutation",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 21, 2018 / 1:11 PM / Updated 11 minutes ago BRIEF-AbbVie and International Myeloma Foundation Partner To Study Role Of Genetic Mutation Reuters Staff 1 Min Read March 21 (Reuters) - AbbVie Inc: * ABBVIE AND THE INTERNATIONAL MYELOMA FOUNDATION ANNOUNCE PARTNERSHIP TO STUDY THE ROLE OF A GENETIC MUTATION IN OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA * ABBVIE INC - ‍STUDY WILL ASSESS OUTCOMES FROM 1,500 PATIENTS WITH MM AND T(11;14) TRANSLOCATION​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-21T15:09:00.000+02:00",
    "crawled": "2018-03-21T15:29:14.002+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "international",
        "myeloma",
        "foundation",
        "partner",
        "study",
        "role",
        "genetic",
        "mutation",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "abbvie",
        "inc",
        "abbvie",
        "international",
        "myeloma",
        "foundation",
        "announce",
        "partnership",
        "study",
        "role",
        "genetic",
        "mutation",
        "outcome",
        "patient",
        "multiple",
        "myeloma",
        "abbvie",
        "inc",
        "assess",
        "outcome",
        "patient",
        "mm",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}